Eduardo Vilar Gomez

Summary

Affiliation: Ciudad de La Habana
Country: Cuba

Publications

  1. pmc Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial
    Eduardo Vilar Gomez
    Department of researches, National Institute of Gastroenterology, Havana, Cuba
    BMJ Open 1:e000140. 2011
  2. ncbi The natural history of compensated HCV-related cirrhosis: a prospective long-term study
    Eduardo Vilar Gomez
    Department of researches, National Institute of Gastroenterology, Havana, Cuba
    J Hepatol 58:434-44. 2013
  3. ncbi Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Liver Int 27:247-59. 2007
  4. pmc Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease
    Eduardo Vilar Gomez
    National Institute of Gastroenterology, Vedado, Havana, Cuba
    World J Gastroenterol 15:2768-77. 2009
  5. doi Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
    E Vilar Gomez
    Departments of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Aliment Pharmacol Ther 30:999-1009. 2009
  6. pmc Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, 25th Avenue, 503, Vedado, Havana 10400, Cuba
    World J Gastroenterol 16:2638-47. 2010
  7. ncbi Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis
    Eduardo Vilar Gomez
    Department of Research and Clinical Experimentation, National Institute of Gastroenterology, Havana, Cuba
    PLoS ONE 9:e95736. 2014

Collaborators

  • Luis Calzadilla Bertot
  • Eduardo Vilar Gomez
  • Luis Calzadilla Bertot
  • Ali Yasells Garcia
  • Yadina Martinez Perez
  • Enrique Arus Soler
  • Yoan Sanchez Rodriguez
  • Ana Torres Gonzalez
  • Maria del Rosario Abreu Vazquez
  • Luis Perez Blanco
  • Licet Gonzalez Fabian
  • Hector Vega Sanchez
  • Gretel Riveron Forment
  • Bienvenido Gra Oramas
  • Raimundo Llanio Navarro
  • Javier Diaz Elias
  • Oscar Villa JimĂ©nez

Detail Information

Publications7

  1. pmc Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial
    Eduardo Vilar Gomez
    Department of researches, National Institute of Gastroenterology, Havana, Cuba
    BMJ Open 1:e000140. 2011
    ..Trial registration number http://ClinicalTrials.gov (NCT00502086)...
  2. ncbi The natural history of compensated HCV-related cirrhosis: a prospective long-term study
    Eduardo Vilar Gomez
    Department of researches, National Institute of Gastroenterology, Havana, Cuba
    J Hepatol 58:434-44. 2013
    ..The natural history of HCV-related compensated cirrhosis has been poorly investigated in Latin-American countries. Our study evaluated mortality and clinical outcomes in compensated cirrhotic patients followed for 6 years...
  3. ncbi Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Liver Int 27:247-59. 2007
    ..Previous trials suggested that antioxidative therapy may have a beneficial effect. We evaluated the efficacy and safety of Viusid in combination with interferon alpha-2b (IFN alpha-2b) and ribavirin in patients with CHC...
  4. pmc Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease
    Eduardo Vilar Gomez
    National Institute of Gastroenterology, Vedado, Havana, Cuba
    World J Gastroenterol 15:2768-77. 2009
    ..To investigate the capability of a biochemical and clinical model, BioCliM, in predicting the survival of cirrhotic patients...
  5. doi Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
    E Vilar Gomez
    Departments of Hepatology, National Institute of Gastroenterology, Havana, Cuba
    Aliment Pharmacol Ther 30:999-1009. 2009
    ..The combination of weight loss and antioxidant drugs to ameliorate insulin resistance and improve steatosis, inflammation and fibrosis provides the rational for therapeutic trials...
  6. pmc Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C
    Eduardo Vilar Gomez
    Department of Hepatology, National Institute of Gastroenterology, 25th Avenue, 503, Vedado, Havana 10400, Cuba
    World J Gastroenterol 16:2638-47. 2010
    ..To investigate the efficacy of Viusid, a nutritional supplement, as an antioxidant and an immunomodulator in patients with chronic hepatitis C...
  7. ncbi Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis
    Eduardo Vilar Gomez
    Department of Research and Clinical Experimentation, National Institute of Gastroenterology, Havana, Cuba
    PLoS ONE 9:e95736. 2014
    ..Therefore, we evaluated the relationship between arterial BP and ascites development in compensated cirrhotic patients...